𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PointBreak: A Randomized Phase III Study of Pemetrexed Plus Carboplatin and Bevacizumab Followed by Maintenance Pemetrexed and Bevacizumab Versus Paclitaxel Plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients With Stage IIIB or IV Nonsquamous Non-Small-Cell Lung Cancer

✍ Scribed by Patel, J. D.; Socinski, M. A.; Garon, E. B.; Reynolds, C. H.; Spigel, D. R.; Olsen, M. R.; Hermann, R. C.; Jotte, R. M.; Beck, T.; Richards, D. A.; Guba, S. C.; Liu, J.; Frimodt-Moller, B.; John, W. J.; Obasaju, C. K.; Pennella, E. J.; Bonomi, P.; Govindan, R.


Book ID
121424670
Publisher
American Society of Clinical Oncology
Year
2013
Tongue
English
Weight
243 KB
Volume
31
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Treatment Rationale and Study Design for
Induction Pemetrexed and Cisplatin Follo